Bamco Inc. NY Grows Stake in Novanta Inc. $NOVT

Bamco Inc. NY raised its holdings in Novanta Inc. (NASDAQ:NOVT) by 101.6% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 627,093 shares of the technology company’s stock after buying an additional 315,978 shares during the quarter. Bamco Inc. NY owned about 1.75% of Novanta worth $62,803,000 at the end of the most recent quarter.

Other hedge funds have also recently made changes to their positions in the company. AQR Capital Management LLC lifted its stake in Novanta by 78.9% in the first quarter. AQR Capital Management LLC now owns 4,231 shares of the technology company’s stock worth $537,000 after acquiring an additional 1,866 shares during the period. Goldman Sachs Group Inc. increased its position in Novanta by 1.6% during the 1st quarter. Goldman Sachs Group Inc. now owns 419,037 shares of the technology company’s stock valued at $53,582,000 after purchasing an additional 6,533 shares during the period. Jane Street Group LLC raised its holdings in Novanta by 1,762.5% in the 1st quarter. Jane Street Group LLC now owns 61,631 shares of the technology company’s stock worth $7,881,000 after purchasing an additional 58,322 shares in the last quarter. PNC Financial Services Group Inc. lifted its position in shares of Novanta by 27.8% in the 2nd quarter. PNC Financial Services Group Inc. now owns 3,747 shares of the technology company’s stock worth $483,000 after purchasing an additional 815 shares during the period. Finally, Geode Capital Management LLC lifted its position in shares of Novanta by 1.4% in the 2nd quarter. Geode Capital Management LLC now owns 919,666 shares of the technology company’s stock worth $118,585,000 after purchasing an additional 12,789 shares during the period. 98.35% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on NOVT. Weiss Ratings upgraded shares of Novanta from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Tuesday, January 20th. Robert W. Baird set a $150.00 price objective on shares of Novanta in a report on Wednesday, February 25th. Finally, Zacks Research raised Novanta from a “strong sell” rating to a “hold” rating in a research report on Friday, January 16th. Three investment analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, Novanta currently has an average rating of “Hold” and a consensus price target of $150.00.

Insider Transactions at Novanta

In other news, CFO Robert Buckley sold 1,423 shares of Novanta stock in a transaction that occurred on Friday, February 20th. The shares were sold at an average price of $140.88, for a total transaction of $200,472.24. Following the completion of the transaction, the chief financial officer directly owned 93,814 shares in the company, valued at approximately $13,216,516.32. This trade represents a 1.49% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Matthijs Glastra sold 7,500 shares of the business’s stock in a transaction that occurred on Tuesday, February 10th. The stock was sold at an average price of $145.04, for a total value of $1,087,800.00. Following the completion of the sale, the chief executive officer directly owned 57,367 shares in the company, valued at approximately $8,320,509.68. This represents a 11.56% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last 90 days, insiders sold 24,346 shares of company stock worth $3,382,737. Corporate insiders own 1.20% of the company’s stock.

Novanta Stock Performance

Shares of Novanta stock opened at $116.76 on Monday. Novanta Inc. has a 12 month low of $98.27 and a 12 month high of $149.95. The firm has a market capitalization of $4.17 billion, a P/E ratio of 79.97 and a beta of 1.61. The company has a current ratio of 3.69, a quick ratio of 2.80 and a debt-to-equity ratio of 0.16. The business has a fifty day simple moving average of $135.29 and a two-hundred day simple moving average of $121.19.

Novanta (NASDAQ:NOVT) last released its earnings results on Monday, February 23rd. The technology company reported $0.91 earnings per share for the quarter, topping analysts’ consensus estimates of $0.88 by $0.03. The firm had revenue of $258.35 million for the quarter, compared to the consensus estimate of $260.72 million. Novanta had a net margin of 5.49% and a return on equity of 13.12%. During the same period in the prior year, the firm earned $0.76 EPS. Novanta has set its FY 2026 guidance at 3.500-3.650 EPS and its Q1 2026 guidance at 0.750-0.800 EPS. On average, equities analysts forecast that Novanta Inc. will post 3.03 earnings per share for the current fiscal year.

About Novanta

Novanta, Inc (NASDAQ: NOVT) is a global technology company that designs and manufactures precision components, subsystems and software used in advanced photonics and motion control applications. The company serves customers in the medical device and advanced industrial markets, supplying critical technologies for diagnostics and therapeutic systems, semiconductor and electronics manufacturing, and scientific instrumentation. Novanta’s product portfolio includes laser control modules, optics, beam delivery systems, high-precision motors, actuators, stages, and fluidics solutions designed to meet stringent accuracy and reliability requirements.

Novanta’s Photonics segment delivers laser and energy delivery components that enable minimally invasive surgical procedures and diagnostic imaging.